A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial InfarctionBr Med J 1974; 1 doi: http://dx.doi.org/10.1136/bmj.1.5905.436 (Published 09 March 1974) Cite this as: Br Med J 1974;1:436
- P. C. Elwood,
- A. L. Cochrane,
- M. L. Burr,
- P. M. Sweetnam,
- G. Williams,
- E. Welsby,
- S. J. Hughes,
- R. Renton
The results of a randomized controlled trial of a single daily dose of acetyl salicylic acid (aspirin) in the prevention of reinfarction in 1,239 men who had had a recent myocardial infarct were statistically inconclusive. Nevertheless, they showed a reduction in total mortality of 12% at six months and 25% at twelve months after admission to the trial. Further trials are urgently required to establish whether or not this effect is real.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial